Assetmark, Inc Staar Surgical CO Transaction History

Assetmark, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$50.45 - $72.82 $24,518 - $35,390	-486 Reduced 64.03%	273 $14,000
Q1 2023 May 05, 2023	BUY	$51.25 - $79.34 $5,842 - $9,044	114 Added 17.67%	759 $48,000
Q4 2022 Feb 10, 2023	BUY	$46.82 - $76.2 $8,942 - $14,554	191 Added 42.07%	645 $31,000
Q3 2022 Nov 01, 2022	BUY	$70.55 - $111.58 $14,392 - $22,762	204 Added 81.6%	454 $32,000
Q2 2022 Aug 03, 2022	BUY	$50.24 - $80.48 $9,897 - $15,854	197 Added 371.7%	250 $18,000
Q1 2022 May 13, 2022	BUY	$57.98 - $93.5 $3,072 - $4,955	53 New	53 $4,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.